These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 19707908

  • 1. Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: immunohistochemical correlations.
    Herlin G, Kölbeck KG, Menzel PL, Svensson L, Aspelin P, Capitanio A, Axelsson R.
    Acta Radiol; 2009 Oct; 50(8):902-8. PubMed ID: 19707908
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
    Menda Y, Kahn D.
    Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
    Karathanos E, Datseris I, Vlontzou E, Zisimopoulos A, Georgiou E.
    J BUON; 2010 Apr; 15(1):147-52. PubMed ID: 20414943
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
    Grewal RK, Dadparvar S, Yu JQ, Babaria CJ, Cavanaugh T, Sherman M, Jacobstein J.
    Cancer J; 2002 Apr; 8(5):400-4. PubMed ID: 12416898
    [Abstract] [Full Text] [Related]

  • 6. Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.
    Apostolopoulos DJ, Koletsis EN, Spyridonidis T, Paschali A, Papandrianos N, Stamou E, Vassilakos PJ, Dougenis D.
    Ann Nucl Med; 2014 Jun; 28(5):463-71. PubMed ID: 24668640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
    Axelsson R, Herlin G, Bååth M, Aspelin P, Kölbeck KG.
    Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
    [Abstract] [Full Text] [Related]

  • 9. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
    Wang F, Wang Z, Wu J, Qu W, Yao W, Zhao J, Liu Z.
    Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351
    [Abstract] [Full Text] [Related]

  • 10. Experimental study of 99mTc-depreotide preparation and its affinity with A549 cell.
    Xia W, Zhang X, Yu F, Wang P, Cai H, Hou R, Wang G, Yuan X, Lv Z.
    Front Biosci (Landmark Ed); 2011 Jun 01; 16(7):2527-39. PubMed ID: 21622193
    [Abstract] [Full Text] [Related]

  • 11. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A, Bernhardt P, Nilsson O, Ahlman H, Kölby L, Forssell-Aronsson E.
    Cancer Biother Radiopharm; 2005 Apr 01; 20(2):231-6. PubMed ID: 15869461
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Somatostatin receptor scintigraphy with 99mTc-Depreotide (NeoSpect) in discriminating between malignant and benign lesions in the diagnosis of lung cancer: a pilot study.
    Bååth M, Kölbeck KG, Danielsson R.
    Acta Radiol; 2004 Dec 01; 45(8):833-9. PubMed ID: 15690613
    [Abstract] [Full Text] [Related]

  • 14. Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.
    Van Den Bossche B, Van Belle S, De Winter F, Signore A, Van de Wiele C.
    J Nucl Med; 2006 Jan 01; 47(1):6-13. PubMed ID: 16391181
    [Abstract] [Full Text] [Related]

  • 15. Imaging of regional lymph node metastases with 99mTc-depreotide in patients with lung cancer.
    Danielsson R, Bååth M, Svensson L, Forslöv U, Kölbeck KG.
    Eur J Nucl Med Mol Imaging; 2005 Aug 01; 32(8):925-31. PubMed ID: 15841374
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
    Cholewinski W, Kowalczyk JR, Stefaniak B, Stefaniak J, Poniatowicz-Frasunek E, Tarkowska A.
    Eur J Nucl Med Mol Imaging; 2004 Jun 01; 31(6):820-4. PubMed ID: 14762697
    [Abstract] [Full Text] [Related]

  • 17. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.
    Rodrigues M, Li S, Gabriel M, Heute D, Greifeneder M, Virgolini I.
    J Clin Endocrinol Metab; 2006 Oct 01; 91(10):3997-4000. PubMed ID: 16895961
    [Abstract] [Full Text] [Related]

  • 18. 99mTc-depreotide in the evaluation of bone infection and inflammation.
    Papathanasiou ND, Rondogianni PE, Pianou NK, Karampina PA, Vlontzou EA, Datseris IE.
    Nucl Med Commun; 2008 Mar 01; 29(3):239-46. PubMed ID: 18349794
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of (99m)tc-depreotide uptake in oesophageal cancer and precursor conditions and its reflection in immunohistochemically detected somatostatin receptors.
    Herlin G, Lundell L, Ost A, Aspelin P, Svensson L, Axelsson R.
    Radiol Res Pract; 2012 Mar 01; 2012():415616. PubMed ID: 22550583
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
    Płachcińska A, Mikołajczak R, Kozak J, Rzeszutek K, Kuśmierek J.
    Nucl Med Rev Cent East Eur; 2006 Mar 01; 9(1):24-9. PubMed ID: 16791800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.